Demo Sign up Log In

Keros Therapeutics Inc (KROS)

CapEx to Depreciation

0.39×

Quarterly · Period ending: Jun 30, 2026

KROS CapEx to Depreciation

Latest reported0.39×period endingJun 30, 2026

Latest reported0.39×period endingJun 30, 2026

KROS Quarterly CapEx/Depreciation (0.00× → 0.39×)

Latest values, visible window

High-resolution chart · PNG

KROS capex to depreciation history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc CapEx to Depreciation — Quarterly
Period ending	CapEx to Depreciation
Jun 30, 2026	0.3856×
Mar 31, 2026	0.1811×
Dec 31, 2025	0.335×
Sep 30, 2025	0.3342×
Jun 30, 2025	1.9459×
Mar 31, 2025	1.6424×
Dec 31, 2024	0.8705×
Sep 30, 2024	1.2293×
Jun 30, 2024	1.0131×
Mar 31, 2024	3.4152×
Dec 31, 2023	2.1903×
Sep 30, 2023	2.619×
Jun 30, 2023	1.6283×
Mar 31, 2023	6.3593×
Dec 31, 2022	2.7638×
Sep 30, 2022	1.3968×
Jun 30, 2022	1.8409×
Mar 31, 2022	1.3009×
Dec 31, 2021	1.5288×
Sep 30, 2021	1.4078×
Jun 30, 2021	5.6044×
Mar 31, 2021	2.625×
Dec 31, 2020	0.8×
Sep 30, 2020	0.4167×
Jun 30, 2020	0.4118×
Mar 31, 2020	2.7937×
Dec 31, 2019	0.3051×
Sep 30, 2019	1.4909×
Jun 30, 2019	3.4898×
Mar 31, 2019	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.